New links between inflammation and thrombosis.

This article is a summary of the Sol Sherry Lecture of the Council on Arteriosclerosis, Thrombosis, and Vascular Biology, which was presented at the Scientific Sessions of the American Heart Association in November 2004. It highlights work from our laboratory, focusing mainly on new aspects of P-selectin and CD40L (CD154) biology and on the interplay of platelets and leukocytes in thrombosis and inflammation.

[1]  T. Springer,et al.  Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins , 1991, Cell.

[2]  D. Wagner,et al.  Pro-coagulant state resulting from high levels of soluble P-selectin in blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Alexander.  The vessel wall. , 1995, The American journal of cardiology.

[4]  I. Charo,et al.  Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. , 1993, The Journal of biological chemistry.

[5]  J. Banchereau,et al.  CD40‐CD40 ligand , 2000, Journal of leukocyte biology.

[6]  A. LaCasce,et al.  Blood cell dynamics in P-selectin-deficient mice. , 1995, Blood.

[7]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[8]  R. Hynes,et al.  Platelet-endothelial interactions in inflamed mesenteric venules. , 1998, Blood.

[9]  D. Bainton,et al.  GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. , 1989, The Journal of clinical investigation.

[10]  D. Wagner,et al.  A new role in hemostasis for the adhesion receptor P-selectin. , 2004, Trends in molecular medicine.

[11]  T. Wakefield,et al.  Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. , 2005, Blood.

[12]  B. Østerud,et al.  Tissue factor: (patho)physiology and cellular biology , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  K. Ley,et al.  Role of platelets in the development of atherosclerosis. , 2004, Trends in cardiovascular medicine.

[14]  D. Wagner,et al.  Adhesion molecules--Part II: Blood vessels and blood cells. , 1996, The New England journal of medicine.

[15]  R. Hynes,et al.  CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism , 2002, Nature Medicine.

[16]  T. Mayadas,et al.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice , 1993, Cell.

[17]  K. Ley.  The role of selectins in inflammation and disease. , 2003, Trends in molecular medicine.

[18]  I. Feuerstein,et al.  Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). , 1994, Blood.

[19]  M. Gawaz,et al.  A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.

[20]  R. C. Johnson,et al.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Wagner,et al.  PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. , 1989, Blood.

[22]  C. Benjamin,et al.  Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets , 1992, Nature.

[23]  R. Kroczek,et al.  The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. , 2001, Blood.

[24]  D. Wagner,et al.  P-selectin and leukocyte microparticles are associated with venous thrombogenesis. , 2003, Journal of vascular surgery.

[25]  D. Wagner,et al.  Inducible secretion of large, biologically potent von Willebrand factor multimers , 1986, Cell.

[26]  T. Mayadas,et al.  Role of P-Selectin Cytoplasmic Domain in Granular Targeting In Vivo and in Early Inflammatory Responses , 1998, The Journal of cell biology.

[27]  R. Hynes,et al.  Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. , 2000, Blood.

[28]  M. Disdier,et al.  Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. , 1992, Molecular biology of the cell.

[29]  P. Burger,et al.  Platelet P-selectin facilitates atherosclerotic lesion development. , 2003, Blood.

[30]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[31]  D. Wagner,et al.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells , 1982, The Journal of cell biology.

[32]  J. Badimón,et al.  Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. , 2000, Blood.

[33]  Andreas Schober,et al.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.

[34]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Wagner,et al.  Leukocyte-endothelium adhesion molecules in atherosclerosis. , 1998, The Journal of laboratory and clinical medicine.

[36]  Nigel Mackman,et al.  Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. , 2004, Blood.

[37]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[38]  D. Phillips,et al.  Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. , 1993, The Journal of biological chemistry.

[39]  M. Daemen,et al.  Requirement for CD154 in the progression of atherosclerosis , 1999, Nature Medicine.

[40]  P. Ridker,et al.  Soluble P-Selectin and the Risk of Future Cardiovascular Events , 2001, Circulation.

[41]  D. Phillips,et al.  Soluble CD40 ligand induces β3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.